NMNina Matthes

Nina Matthes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nina Matthes has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immune checkpoint inhibitor-induced Wells syndrome in a patient with stage IV melanoma successfully treated with mepolizumab: a case report

    by Nina Matthes, Nina Booken, Noah Zimmermann, Anne Menz, Christoffer Gebhardt, Stefan W Schneider, Julian Kött

    Cutaneous immune-related adverse events (irAEs) represent the most common toxic manifestations of anti-programmed cell death protein 1 checkpoint inhibitor therapy, yet their clinical spectrum continues to expand. We report the first case of immune checkpoint inhibitor-induced Wells syndrome (eosinophilic cellulitis) in a 32-year-old man with stage IV malignant melanoma receiving adjuvant pembrolizumab following a pathologically complete response to neoadjuvant treatment of bilateral inguinal lymph node metastases. The patient presented with a 1-week history of intensely pruritic, erythematous, annularly arranged urticarial plaques distributed over the arms, thighs and trunk, accompanied by peripheral eosinophilia (0.6 × 109 cells L–1). A punch biopsy of a representative lesion revealed diffuse eosinophilic infiltrates and flame figure formation in the upper dermis, establishing the diagnosis of Wells syndrome. Intravenous prednisolone was initiated at 150 mg daily in accordance with current irAE management guidelines and escalated to 160 mg daily in response to worsening eosinophilia (2.33 × 109 cells L–1). Despite high-dose corticosteroid therapy, the eosinophil count continued to rise (3.04 × 109 cells L–1) and cutaneous involvement persisted. Following interdisciplinary tumour board approval, a single subcutaneous dose of mepolizumab 300 mg was administered on hospital day 8. Mepolizumab is a humanized monoclonal antibody that targets circulating interleukin (IL)-5, inhibiting eosinophil maturation, activation and survival. The patient tolerated the treatment well, with complete resolution of peripheral eosinophilia within 5 days (0.31 × 109 cells L–1) and marked improvement in his cutaneous lesions. Prednisolone was successfully tapered to a maintenance dose of 5 mg. Patient-reported outcomes improved substantially, with the Dermatology Life Quality Index decreasing from 28 to 6 and the WHO-5 Well-being Index increasing from 1 to 14 at the 2-month follow-up, reflecting a clinically meaningful recovery in quality of life. This case demonstrates that Wells syndrome should be considered within the differential diagnosis of rare cutaneous irAEs. Its IL-5-driven pathophysiology provides a mechanistic rationale for targeted anti-IL-5 therapy. Prompt histopathological workup and awareness of this entity may reduce diagnostic delay, facilitate steroid-sparing strategies and improve outcomes in refractory cutaneous irAEs.

  • Open Access

    Current skin of color representation in medical school dermatology education in Germany, Austria and Switzerland (DACH region)

    by Nina Matthes, Julian Kött, Ines Heinen, Nina Booken, Stefan W. Schneider, Finn Abeck

    Summary: Background and objectives: Dermatologic diagnosis relies heavily on visual recognition, yet educational resources predominantly depict lighter skin types. While underrepresentation of Skin of Color (SoC) in medical education has been demonstrated in North America, data from German‐speaking countries remain lacking. This study assesses the SoC representation in dermatology curricula in the DACH region (Germany, Austria, Switzerland). Methods: We conducted a questionnaire‐based study targeting dermatology departments at all medical schools in the DACH region (n = 57). Results: The response rate was 65%. 89% (33/37) rated SoC curriculum integration as important or very important. 65% (24/37) already implemented SoC education in mandatory teaching. Among these, 83% (20/24) introduced SoC content within the previous 4 years. Main barriers to integration are lack of teaching materials (62%, 23/37), insufficient expertise (24%, 9/37) and limited curriculum time (22%, 8/37). 14% (5/37) reported including questions on SoC dermatology in final examinations. Conclusions: SoC is recognized as an important component of dermatology education in the DACH region. However, implementation remains inconsistent, as over a third of faculties do not offer mandatory SoC education. Access to high‐quality teaching materials can be considered a key factor in strengthening SoC education. Further efforts are needed to promote diversity‐sensitive education.

  • Open Access

    Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

    by Nina Matthes, Julian Kött, Finn Abeck, Inga Hansen‐Abeck, Jana Bertels, Nina Booken, Stefan W. Schneider


  • Open Access

    Perceptions of Stigma Among Patients With Hepatitis B in Germany: Cross-Sectional Survey

    by Bettina M Zimmermann, Theresa Willem, Michael Rost, Nina Matthes, Alena Buyx

    Background: Many studies find associations between hepatitis B and stigma, but studies from the Western European context are lacking. Based on available studies, we hypothesized that younger age, higher education, male gender, higher privacy needs, and non-German mother tongue were positively associated with perceived hepatitis B–related stigma. Objective: This study aims to describe the prevalence of perceived social stigma among patients with hepatitis B in Germany and to assess what factors are associated with perceptions of hepatitis B–related stigma. Methods: Applying the short version of the Berger stigma scale, we surveyed 195 patients with hepatitis B about their perceptions of hepatitis B–related stigma, privacy needs, and demographic variables through a paper-based questionnaire. Venue-based recruitment of adult patients diagnosed with acute or chronic hepatitis B was implemented at 3 clinical centers in Germany. Patients who could not read German were excluded from the study. Results: From the 195 valid questionnaires, 45.1% (88/195) of participants identified as female, 36.6% (71/195) had a high school diploma, and 56.9% (111/195) reported a mother tongue other than German. The mean (SD) stigma score throughout the sample was 5.52 (6.02; range 0-24) and the median was 3.50 (IQR=9.75). Regression analysis revealed that non-German mother tongue, individual data privacy needs, and participants’ secrecy regarding their hepatitis B diagnosis independently predicted perceived hepatitis B-related stigma. More precisely, the higher the data privacy need and the more secret the hepatitis B diagnosis, the higher the perceived stigma, and perceived stigma was higher for patients with a non-German mother tongue. Age, gender, and education were no predictors of perceived stigma. Conclusions: The surveyed patients with hepatitis B in Germany reported lower levels of hepatitis B–related stigma than found in other studies conducted in Asian countries. The association with non-German mother tongue indicates an important cultural and social component in the perception of stigma. Community-based interventions and the sensibilization of health care professionals might help overcome perceptions of stigma among hepatitis B–affected populations.


  • Open Access

    Social Media Recruitment as a Potential Trigger for Vulnerability: Multistakeholder Interview Study

    by Nina Matthes, Theresa Willem, Alena Buyx, Bettina M Zimmermann

    Background: More clinical studies use social media to increase recruitment accrual. However, empirical analyses focusing on the ethical aspects pertinent when targeting patients with vulnerable characteristics are lacking. Objective: This study aims to explore expert and patient perspectives on vulnerability in the context of social media recruitment and seeks to explore how social media can reduce or amplify vulnerabilities. Methods: As part of an international consortium that tests a therapeutic vaccine against hepatitis B (TherVacB), we conducted 30 qualitative interviews with multidisciplinary experts in social media recruitment (from the fields of clinical research, public relations, psychology, ethics, philosophy, law, and social sciences) about the ethical, legal, and social challenges of social media recruitment. We triangulated the expert assessments with the perceptions of 6 patients with hepatitis B regarding social media usage and attitudes relative to their diagnosis. Results: Experts perceived social media recruitment as beneficial for reaching hard-to-reach populations and preserving patient privacy. Features that may aggravate existing vulnerabilities are the acontextual point of contact, potential breaches of user privacy, biased algorithms disproportionately affecting disadvantaged groups, and technological barriers such as insufficient digital literacy skills and restricted access to relevant technology. We also report several practical recommendations from experts to navigate these triggering effects of social media recruitment, including transparent communication, addressing algorithm bias, privacy education, and multichannel recruitment. Conclusions: Using social media for clinical study recruitment can mitigate and aggravate potential study participants’ vulnerabilities. Researchers should anticipate and address the outlined triggering effects within this study’s design and proactively define strategies to overcome them. We suggest practical recommendations to achieve this.


  • Open Access

    Acceptance of Social Media Recruitment for Clinical Studies Among Patients With Hepatitis B: Mixed Methods Study

    by Theresa Willem, Bettina M Zimmermann, Nina Matthes, Michael Rost, Alena Buyx

    Background: Social media platforms are increasingly used to recruit patients for clinical studies. Yet, patients’ attitudes regarding social media recruitment are underexplored. Objective: This mixed methods study aims to assess predictors of the acceptance of social media recruitment among patients with hepatitis B, a patient population that is considered particularly vulnerable in this context. Methods: Using a mixed methods approach, the hypotheses for our survey were developed based on a qualitative interview study with 6 patients with hepatitis B and 30 multidisciplinary experts. Thematic analysis was applied to qualitative interview analysis. For the cross-sectional survey, we additionally recruited 195 patients with hepatitis B from 3 clinical centers in Germany. Adult patients capable of judgment with a hepatitis B diagnosis who understood German and visited 1 of the 3 study centers during the data collection period were eligible to participate. Data analysis was conducted using SPSS (version 28; IBM Corp), including descriptive statistics and regression analysis. Results: On the basis of the qualitative interview analysis, we hypothesized that 6 factors were associated with acceptance of social media recruitment: using social media in the context of hepatitis B (hypothesis 1), digital literacy (hypothesis 2), interest in clinical studies (hypothesis 3), trust in nonmedical (hypothesis 4a) and medical (hypothesis 4b) information sources, perceiving the hepatitis B diagnosis as a secret (hypothesis 5a), attitudes toward data privacy in the social media context (hypothesis 5b), and perceived stigma (hypothesis 6). Regression analysis revealed that the higher the social media use for hepatitis B (hypothesis 1), the higher the interest in clinical studies (hypothesis 3), the more trust in nonmedical information sources (hypothesis 4a), and the less secrecy around a hepatitis B diagnosis (hypothesis 5a), the higher the acceptance of social media as a recruitment tool for clinical hepatitis B studies. Conclusions: This mixed methods study provides the first quantitative insights into social media acceptance for clinical study recruitment among patients with hepatitis B. The study was limited to patients with hepatitis B in Germany but sets out to be a reference point for future studies assessing the attitudes toward and acceptance of social media recruitment for clinical studies. Such empirical inquiries can facilitate the work of researchers designing clinical studies as well as ethics review boards in balancing the risks and benefits of social media recruitment in a context-specific manner.


  • Open Access

    Acceptance of Social Media Recruitment for Clinical Studies Among Patients With Hepatitis B: Mixed Methods Study (Preprint)

    by Theresa Willem, Bettina M Zimmermann, Nina Matthes, Michael Rost, Alena Buyx

    BACKGROUND Social media platforms are increasingly used to recruit patients for clinical studies. Yet, patients’ attitudes regarding social media recruitment are underexplored. OBJECTIVE This mixed methods study aims to assess predictors of the acceptance of social media recruitment among patients with hepatitis B, a patient population that is considered particularly vulnerable in this context. METHODS Using a mixed methods approach, the hypotheses for our survey were developed based on a qualitative interview study with 6 patients with hepatitis B and 30 multidisciplinary experts. Thematic analysis was applied to qualitative interview analysis. For the cross-sectional survey, we additionally recruited 195 patients with hepatitis B from 3 clinical centers in Germany. Adult patients capable of judgment with a hepatitis B diagnosis who understood German and visited 1 of the 3 study centers during the data collection period were eligible to participate. Data analysis was conducted using SPSS (version 28; IBM Corp), including descriptive statistics and regression analysis. RESULTS On the basis of the qualitative interview analysis, we hypothesized that 6 factors were associated with acceptance of social media recruitment: using social media in the context of hepatitis B (hypothesis 1), digital literacy (hypothesis 2), interest in clinical studies (hypothesis 3), trust in nonmedical (hypothesis 4a) and medical (hypothesis 4b) information sources, perceiving the hepatitis B diagnosis as a secret (hypothesis 5a), attitudes toward data privacy in the social media context (hypothesis 5b), and perceived stigma (hypothesis 6). Regression analysis revealed that the higher the social media use for hepatitis B (hypothesis 1), the higher the interest in clinical studies (hypothesis 3), the more trust in nonmedical information sources (hypothesis 4a), and the less secrecy around a hepatitis B diagnosis (hypothesis 5a), the higher the acceptance of social media as a recruitment tool for clinical hepatitis B studies. CONCLUSIONS This mixed methods study provides the first quantitative insights into social media acceptance for clinical study recruitment among patients with hepatitis B. The study was limited to patients with hepatitis B in Germany but sets out to be a reference point for future studies assessing the attitudes toward and acceptance of social media recruitment for clinical studies. Such empirical inquiries can facilitate the work of researchers designing clinical studies as well as ethics review boards in balancing the risks and benefits of social media recruitment in a context-specific manner.